Defective interfering (DI) particles of influenza virus contain subgenomic RNAs which are standard gene segments with internal deletions (for a review, see reference 25) . The replication of DI particles depends upon helper functions provided by standard influenza virus. DI particles interfere with the replication of the helper virus and can modify standard viral pathogenesis in experimental animals (for a review, see references 2 and 25). Depending on the virus/host system and dosage used, DI particles may protect a host from lethal infection (16, 27, 30) , prolong the course of the disease (17) , or convert the acute infection to a persistent state (14) . DI particles are easily generated under laboratory conditions. However, whether DI particles occur in natural influenza virus infections and whether they can modulate the pathogenicity of virus outbreaks, as suggested by Huang and Baltimore (18) , are unanswered questions.
In April 1983, an H5N2 influenza virus outbreak occurred with low mortality in poultry in the eastern United States. The virus first isolated from this outbreak, A/Chicken/Pennsylvania/1/83 (CP1), was avirulent, and RNA preparations from this virus contained subgenomic RNAs (3) . In October 1983, a closely related but highly virulent virus, A/Chicken/Pennsylvania/1370/83 (CP1370), emerged and spread to domestic poultry in four states, causing up to 80% mortality (23) . CP1370 RNA preparations did not contain subgenomic RNAs. In experimental mixed infections, CP1 protected chickens from the pathogenic effect of CP1370 (3). Therefore, it is possible that DI particles associated with CP1 played a role in controlling mortality from the H5N2 virus outbreak in mid-1983, until CP1370 became dominant (3) . If so, this would be the first reported instance of the involvement of DI particles in a natural influenza virus infection.
The experiments in this paper were done to determine whether CP1 contained DI particles, based on analyses of defectiveness, interference with standard virus multiplication, and the primary structure of subgenomic RNAs. Additionally, by screening influenza virus isolates derived from natural sources for subgenomic RNAs, we sought to deter-* Corresponding author. mine whether DI particles are commonly found in natural influenza virus infections. Our results indicate that CP1 contained naturally generated DI particles and that some other influenza virus isolates contained subgenomic RNAs like those of DI particles.
MATERIALS AND METHODS
Viruses and viral RNA. The avirulent CP1 virus (designated 83-21525) was obtained in allantoic fluid from the National Veterinary Services Laboratory, Ames, Iowa. A clonal isolate was obtained by twice-repeated limit-dilution passage in 11-day-old embryonated chicken eggs (23), followed by two egg passages (1:100 dilution) to produce virus stocks for these experiments. To ensure that these manipulations were not responsible for generating the subgenomic RNAs, we obtained the original material from infected chickens from Robert Eckroade, University of Pennsylvania, Philadelphia, and passaged it once in eggs at high dilution. Viral RNA prepared from the last egg passage appeared the same on polyacrylamide gels as did RNA prepared from the first egg passage of the original swabs from chickens.
The virulent CP1370 virus was also obtained in allantoic fluid from the National Veterinary Services Laboratory. A clonal isolate was obtained by repeated plaque purification on chicken embryo fibroblast cells (W. Bean, personal communication) and was amplified by three egg passages (1:100 dilution) to produce virus stocks for these experiments. The resulting virus preparation is similar in virulence and RNA pattern to the uncloned CP1370 preparation. All work with infectious Chicken/Pennsylvania viruses was done in a P3 containment facility.
Other viruses (see Table 4 ) were from the repository of influenza virus isolates at St. Jude Children's Research
Hospital and were grown in embryonated eggs. RNAs of these viruses were prepared from the second egg passage (1:100 dilution) of the original sample. Virus RNAs were prepared as previously described (5) . RNAs were analyzed by electrophoresis on 3% polyacrylamide-7 M urea gels followed by staining with a silver stain kit (Bio-Rad Laboratories, Richmond, Calif.). For in vitro transcription experiments, viruses were purified, pelleted, and suspended as described (5) . Virus protein concentrations (means of four measurements) were determined with a protein assay (Bio-Rad). In vitro transcription reactions were carried out as previously described (13, 26) by using 0.4 mM ApG as the primer. In each reaction, 25 ,uCi of [kx-32P]ATP (Amersham Corp., Arlington Heights, Ill.) was included to radiolabel the transcription products. Reactions were carried out at 31°C, and aliquots were removed at intervals to assay trichloroacetic acid-insoluble radioactivity.
Interference assays. Infectious center reduction assays for quantitation of DI units (DIU) were performed and analyzed by the method of Janda et al. (20) , using chicken embryo fibroblast cells.
For in vivo interference experiments, adult White Leghorn chickens were inoculated with mixed-virus preparations through the nasal cleft. Virus preparations included 104 50% egg infective doses (EID50) of CP1370 plus 106 EID50 of either CP1 or Duck/Michigan/25/80. The two groups of birds were housed in separate cubicles and observed daily for disease signs. Tracheal and cloacal swabs were taken 3 days after inoculation.
Northern blots. Samples of viral RNA were glyoxal denatured, electrophoresed on 1.5% agarose-10 mM sodium phosphate (pH 7.0) gels (29) , and then transferred by capillary blotting to GeneScreen Plus hybridization membranes (DuPont-New England Nuclear Research Products, Boston, Mass.). For analysis of CP1 subgenomic RNAs, six equivalent lanes of blotted CP1 RNA were prepared from a single agarose gel. These six blots were repeatedly reused, by elution of one probe and rehybridization with another, to ensure positive identification of bands from the various hybridizations.
The oligonucleotide probes used (see Table 3 ) matched regions of the published sequences of influenza virus A/NT/60/68 genes (6, 7, 19, 22) . Exceptions were HA-44 and NA-146, which correspond to the published CP1 hemagglutinin (HA) and neuraminidase sequences (15, 23) , and M-8, based on the A/PR/8/34 sequence (33) . Most (31) . The probe concentration was usually 2 x 105 cpm/ml. Hybridizations were carried out at 25°C, except for probes PB1-1375 and NA-146 in which a temperature of 35°C was used to eliminate partial cross-hybridization to other standard gene segments. A modest level of hybridization stringency was used because in most cases we were uncertain of perfect complementarity between the probe and target sequence. Several other probes failed to hybridize to the correct standard gene segment and were not used for analysis. Blots were washed extensively with 6x SSC-0.1% sodium dodecyl sulfate at the hybridization temperature and then sealed without drying into plastic bags for autoradiography. Hybridized probes were eluted from the blots by washing with boiling 0.01 x SSC-0.01% sodium dodecyl sulfate, followed by autoradiography to ensure probe removal.
Densitometric quantitation of autoradiographs was done with a Hoefer GS300 scanning densitometer and a computerized data analysis program developed and kindly provided by Michael Ando and Victor Fried of St. Jude Children's Research Hospital.
RESULTS
In vitro interference by CP1. Interference with standard virus multiplication in vitro was measured by an infectious center reduction assay (10, 20) with Wilson-Smith neurotropic (WSN) virus as the standard virus. The DIU titer of various amounts of CP1 was calculated from cell and infectious center counts by the method of Janda et al. (20) ( Fig. 1 ). For DI preparations of fowl plague virus, such a curve is nonlinear at DIU per cell multiplicities greater than 0.5 to 1 (10), equivalent to 13 RI of CP1 in Fig. 1 . From the initial linear region of Fig. 1 , we determined that the CP1 virus stock contained 9.8 x 106 DIU/ml. This is comparable to values reported for other DI preparations (20) . The same CP1 virus stock contained 7 x 105 PFU/ml. Therefore, a large fraction of CP1 virus particles produce interference with standard viral replication. CP1370 produced negligible interference with WSN virus in this assay.
In vivo interference by CP1. We have confirmed an earlier finding (3) that coinfection of chickens with CP1 protects them from lethal CP1370 infection and additionally have assessed whether protection is due to inhibition of the spread of virulent virus ( Table 1) . Groups of eight adult hens were doubly infected via the nasal cleft with mixtures of either CP1370 plus CP1 or CP1370 plus A/Duck/Michigan/25/80. Duck/Michigan is an avirulent H5N2 virus without subgenomic RNAs (3). In the Duck/Michigan-CP1370 group, there was 100% mortality within 8 days. In the CP1-CP1370 group, only three of eight birds died within this time; a fourth became sick but recovered; four birds showed no disease 105, which is comparable to infectivity ratios approaching 106 for egg-grown fowl plaque virus (9) . The CP1 virus stock had a plaque-forming/hemagglutinating ratio of 1.1 x 104, or 25-fold lower than that of the virulent virus. This also is comparable to laboratory-generated fowl plague DI preparations (9) . Therefore, CP1 is defective as well as interfering, and it resembles laboratory-induced influenza virus DI preparations in both respects.
Since it has been shown that influenza virus defectiveness is sometimes associated with a reduction in the kinetics of in vitro transcription (1, 4, 9, 13), we next compared the primary transcription activity of CP1 and CP1370 in vitro (Fig. 2) . Initial rates of transcription (up to 40 min) were similar for CP1, CP1370, and WSN standard virus. This suggests that CP1 virion RNAs (vRNAs) are not deficient in associated transcriptase enzyme complex, in contrast to results from laboratory-generated DI preparations (1, 13) . CP1370 transcription reached a plateau earlier than CP1 or WSN did. This pattern was found in three separate experiments with two different preparations of CP1370. The apparent lability of CP1370 transcriptase may be due to unknown point mutations in the CP1370 polymerase genes.
We also compared the levels of polymerase genes in CP1, CP1370, and WSN virus RNA preparations by densitometric scanning of autoradiographs of Northern blots hybridized with oligodeoxynucleotide probes (Table 2) . Results were arbitrarily normalized against nucleoprotein (NP) gene levels in the different RNA tracks. Table 2 shows that CP1 RNA was not deficient in polymerase genes compared with CP1370, again in contrast to the RNAs of laboratory-induced DI preparations (1). Both exhibited less polymerase RNA (21) . Figure 3 shows a typical Northern blot, with probes for the specific vRNA 3' ends of each of the three polymerase genes and for the universal influenza A vRNA 5' end. Subgenomic RNA segments 1, 2, and 6 (originally identified on polyacrylamide gels) can be resolved on these blots, but several overlapping bands appear in the region labeled 3,4,5. (Table  4) . These viruses included isolates from wild and domestic ducks, turkeys, swine, gulls, whales, and seals. A variety of influenza virus subtypes were represented. In most cases, the RNA was prepared from the second egg passage (1:100 dilution) of the original sample. RNAs were examined by polyacrylamide gel electrophoresis followed by silver staining. Of 18 virus preparations examined, subgenomic RNAs were detected in 5 (Table 4) . These subgenomic RNAs were usually represented at low levels of mass compared with standard gene levels. To determine if these RNAs were of polymerase gene origin, Northern blots were done on four of the five positive RNA samples by using probes PB1-17, PA-8, and PB2-5. Subgenomic RNAs in each sample hybridized with these probes (Fig. 4) . A pair of PB2-derived subgenomic bands (arrows in Fig. 4 ) appeared nearly identical in the RNA tracks of A/Mallard/Alberta/75/76 and A/Mallard/Alberta/77n6. These were both H3N8 viruses, isolated on the same day from different wild ducks. We were unable to determine if the isolations were made at the same pond. This data suggests transmission of subgenomic RNAbearing viruses among birds. However, other subgenomic RNAs of these viruses did not comigrate. Two other Mal- lard/Alberta viruses isolated at nearly the same time (Table  4) did not show subgenomic RNAs detectable by silver staining. Among other viruses in Table 4 from which subgenomic RNAs were detected, Duck/Minnesota/1086/80 is noteworthy in that extremely low levels of standard polymerase genes were found by both silver staining and Northern blot methods (Fig. 4) . We expect this virus preparation to be highly defective. Reduction in polymerase RNA content has also been observed in several influenza virus DI preparations (1, 25) . Guinea fowl/New York/13801/86 was an isolate from a recent H5N2 poultry epidemic in the eastern United States, the agents of which partly resemble CP1 (W. Bean, personal communication). Its RNA was not analyzed on Northern blots. Together, the above results suggest that (25) believe that the low virus per cell multiplicity of a natural infection is not favorable for the survival of defective viruses which require high multiplicity for rescue by complementation. However, influenza virus replicates to very high titers in the intestinal tracts of ducks; titers up to 6 x 107 EID5Jml in intestinal mucosa and 6 x 108 EID50/ml in feces have been reported (32) . This may be sufficient for the amplification of DI particles in ducks.
We have considered the possibility that DI particles arose during egg passages made after the CP1 virus sample was isolated from chickens. However, these passages were done at low multiplicities of infection and included two limitdilution passages. These conditions do not favor amplification of DI particles (25) . On (24) . Therefore, our results on transcription kinetics and polymerase gene levels do not necessarily contradict the conclusion that CP1 contains DI particles.
Other factors beside DI particles contribute to the lack of virulence of CP1. Cleavability of the HA glycoprotein into HAl and HA2 has been correlated with avian influenza virus pathogenicity for chickens (8) . Sequencing of the CP1 HA gene has revealed a point mutation (relative to CP1370 HA) which generates a potential glycosylation site at amino acid 11 of HAl (23 Symp. on Avian Influenza Virus, in press) have identified H5N2 virus isolates from the same 1983 epidemic that produced CP1; these isolates possess cleavable HA but are still avirulent. Although this may be the product of unknown mutations in other genes, the possibility that DI particles suppress the virulence of the parent viruses has not been discounted.
Coinfection of chickens with CP1 reproducibly protects chickens from death by CP1370 infection. Dimmock et al. (16) have shown that protection of mice from lethal influenza virus by DI particles is not due to inhibition of virus multiplication in lung extracts, induction of interferon, increase in antigen levels, or increase in neutralizing-antibody response. They speculate that, aside from the conventional DI-mediated inhibition of standard virus replication, a second protective activity operates in the mouse system by modulation of host T-cell regulatory networks. Rabinowitz and Huprikar (27) Alternatively, in considering DI-mediated protection of mice from encephalitis by vesicular stomatitis virus, Cave et al. (11, 12) argue that protection is indeed a function of inhibition of virus multiplication. However, in their model this function takes a cyclic form over several generations of virus replication, and the relative DI levels for protection in vivo cannot easily be predicted based on the DI levels for inhibition of cytopathic effect in vitro. Low DI levels may sometimes produce a significant degree of protection (11) . Therefore, it remains conceivable that DI particles associated with CP1 suppress the multiplication of the virulent virus in chickens. The detection of virus 3 days after inoculation from cloacal swabs of unprotected, but not from protected, chickens supports this hypothesis. Studies are underway, by careful examination of infected chicken organs for virus, to determine whether protection against virulent virus by CP1 in the chicken model is due to inhibition of virulent virus multiplication.
